Author :   Martynchyk A.V.

Quality of life level in patients with diffuse large B-cell lymphoma from high-risk group treated with R-DA-EPOCH regimen
Authors: Filonenko K.S. Kryachok I. Stepanishyna Y.A. Martynchyk A.V.... №4(28) 2017
Immunohistochemical c-MYC expression in different subtypes of diffuse large B-cell lymphoma
Authors: Kryachok I. Martynchyk A.V. Filonenko K.S. Stepanishyna Y.A.... №4(28) 2017
MALT-lymphoma: etiology, pathogenesis, classification, clinical issues
Authors: Kryachok I. Ulianchenko K.O. Kadnikova T. Titorenko I.B.... №1(25) 2017
Toxic hepatitis in patients with lymphoproliferative diseases
Authors: Kryachok I. Pastushenko J. Martynchyk A.V. Titorenko I.B. №4(24) 2016
Treatment of HIV-related non-Hodgkin’s lymphomas in the era of highly active antiretroviral therapy
Authors: Kryachok I. Skripets Т.V. Ulianchenko K.O. Titorenko I.B.... №3(23) 2016
Lymphoma and hepatitis C
Authors: Kryachok I. Ulianchenko K.O. Kadnikova T. Titorenko I.B.... №3(23) 2016
Primary mediastinal large B-cell lymphoma. The role of positron emission tomography
Authors: Stepanishyna Y.A. Kryachok I. Titorenko I.B. Filonenko Е.... №3(23) 2016
Necessity of routine computed tomography after the end of the lymphoma treatment
Authors: Kryachok I. Filonenko Е. Martynchyk A.V. Kushchevyi E.V. №3(11) 2013
Cytomegalovirus infection in hematology and oncology patients receiving cytotoxic therapy (review and case report)
Authors: Kushchevyi E.V. Kryachok I. Stepanishyna Y.A. Martynchyk A.V.... №2(10) 2013
What’s new in hematooncology? (Review of the last approaches to the diagnosis and treatment of lymphomas)
Authors: Kryachok I. Filonenko Е. Martynchyk A.V. Novosad I.O. №7 (3) 2012
Biological factors of Hodgkin’s lymphoma prognosis (review)
Authors: Svеrgun N.N. Khranovskaya N.M. Kryachok I. Novosad I.O.... №6 (2) 2012
New approaches to diagnosis and treatment of lymphomas. Review of international conferences
Authors: Kryachok I. Martynchyk A.V. Kushchevyi E.V. Kadnikova T.... №5 (1) 2012

12